What is Ped Lite?
Established in 2006, Ped Lite has carved out a distinct niche as a premier provider of diabetic footwear, custom inserts, and specialized fabrication materials. By bridging the gap between clinical necessity and consumer-grade comfort, the company serves a critical demographic of patients requiring orthopedic support alongside healthcare providers seeking reliable supply chain partners. Their business model prioritizes the synthesis of high-quality manufacturing standards with accessible pricing, ensuring that essential medical equipment remains attainable for those managing chronic conditions. Through a commitment to rigorous quality control and a satisfaction-guaranteed service framework, Ped Lite maintains a competitive advantage in the highly regulated medical device landscape.
How much funding has Ped Lite raised?
Ped Lite has raised a total of $117K across 1 funding round:
Debt
$117K
Debt (2021): $117K with participation from PPP
Key Investors in Ped Lite
PPP
Public-Private Partnership
What's next for Ped Lite?
The deployment of this recent capital is expected to accelerate Ped Lite's market penetration and infrastructure optimization. As the company transitions through this late-stage growth phase, management is likely to focus on scaling its fabrication capabilities and expanding its distribution network to meet the rising demand for specialized diabetic care solutions. By utilizing this debt financing to bolster working capital, Ped Lite is well-positioned to enhance its product development pipeline and strengthen its strategic partnerships with healthcare institutions. The focus remains on maintaining operational excellence while navigating the complexities of the medical supply market, ensuring that the firm remains a leader in the provision of therapeutic footwear and related orthopedic technologies.
See full Ped Lite company page
